ARTICLE | Company News
Hapto, Ortec deal
October 18, 2004 7:00 AM UTC
Hapto Biotech and ORTN formed a JV to develop compounds for wound healing and tissue regeneration. The compounds were identified under a 2002 research deal using Hapto's Haptide synthetic peptide tech...